Projects per year
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Wei-Chiao Chang
- Department of Clinical Pharmacy - Professor
- Master Program in Applied Epidemiology - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Professor
- The Ph.D. Program for Translational Medicine - Joint-Appointment Professor
- Ph.D. Program in Medical Neuroscience - Joint-Appointment Professor
- TMU Research Center of Cancer Translational Medicine - Member
- TMU Research Center of Cell Therapy and Regeneration Medicine - member
Person: Researcher
-
Mei-Chuan Chen
- Department of Pharmaceutical Sciences - Professor
- Graduate Institute of Pharmacognosy - Joint-Appointment Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Professor
- TMU Research Center of Thoracic Medicine - Member
Person: Researcher
-
Yu-Wen Cheng
- Department of Pharmaceutical Sciences - Professor
- Ph.D. Program in Drug Discovery and Development Industry - Joint-Appointment Professor
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine - Joint-Appointment Professor
- Master Program in Clinical Genomics and Proteomics - Joint-Appointment Professor
- Department of Ophthalmology - Joint-Appointment Professor
- TMU Research Center of Drug Discovery - Member
- TMU Research Center of Neuroscience - Member
Person: Researcher
-
Discovery of Bbb-Crossing Drugs Targeting Neuroinflammation for Glioblastoma( III )
Liou, J.-P. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
以化學分子網絡探索海洋藥用資源:台灣海綿活性代謝組成資料庫之建立與應用(1/3)
Lai, K.-H. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Establishing Anti-Inflammatory Metabolomic Database of Tcms Using Chemical Molecular Networking Approach
Lai, K.-H. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
Research output
-
2-Hydroxyl hispolon reverses high glucose-induced endothelial progenitor cell dysfunction through the PI3K/Akt/eNOS and AMPK/HO-1 pathways
Wang, T. J., Hou, W. C., Hsiao, B. Y., Lo, T. H., Chen, Y. T., Yang, C. H., Shih, Y. T. & Liu, J. C., 2025, (Accepted/In press) In: British Journal of Pharmacology.Research output: Contribution to journal › Article › peer-review
Open Access -
Activation of the Trichodimerol Pathway through Deletion of mcrA in Marine Penicillium rubens YAP001
Shyong, J., Tran Huynh, Q. D., Dziedzic, S., Aguirre, E., Rabot, C., Yuan, B., Herrero-MacKenzie, H. E., Stajich, J. E., Lee, C. K., Kenkel, C. D. & Wang, C. C. C., 2025, (Accepted/In press) In: ACS Chemical Biology. 20, 4, p. 823-829 7 p.Research output: Contribution to journal › Article › peer-review
-
Advancing glioblastoma therapy: Learning from the past and innovations for the future
Rana, M., Liou, K. C., Thakur, A., Nepali, K. & Liou, J. P., May 1 2025, In: Cancer Letters. 617, 217601.Research output: Contribution to journal › Article › peer-review
Datasets
-
Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.c.4522856.v1, https://springernature.figshare.com/collections/Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/4522856/1
Dataset
-
Additional file 4: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202896.v1, https://springernature.figshare.com/articles/Additional_file_4_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202896/1
Dataset
-
Additional file 1 of Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer
Liu, E.-S. (Contributor), Wang, C.-K. (Contributor), Chuang, K.-H. (Contributor), Chen, F.-M. (Creator), Wu, T.-H. (Contributor), Chen, C.-Y. (Creator), Chen, I.-J. (Creator), Lin, R.-A. (Creator), Wang, Y.-M. (Contributor), Lu, Y.-C. (Contributor), Liao, T.-Y. (Contributor), Chen, H.-J. (Creator), Cheng, T.-L. (Creator) & Cheng, Y.-A. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12885938.v1, https://doi.org/10.6084%2Fm9.figshare.12885938.v1
Dataset